Loss of SLC45A3 protein (prostein) expression in prostate cancer is associated with SLC45A3-ERG gene rearrangement and an unfavorable clinical course. (Q47355331)

From Wikidata

Jump to navigation Jump to search

scientific article published on 30 August 2012

Language	Label	Description	Also known as
English	Loss of SLC45A3 protein (prostein) expression in prostate cancer is associated with SLC45A3-ERG gene rearrangement and an unfavorable clinical course.	scientific article published on 30 August 2012

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22821757%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Loss of SLC45A3 protein (prostein) expression in prostate cancer is associated with SLC45A3-ERG gene rearrangement and an unfavorable clinical course (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22821757%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22821757%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22821757%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

6

object named as

Manfred Dietel

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22821757%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

5

object named as

Holger Moch

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22821757%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

author name string

Sven Perner

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22821757%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Niels J Rupp

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22821757%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Martin Braun

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22821757%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Nicolas Wernert

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22821757%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Carsten Stephan

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22821757%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Glen Kristiansen

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22821757%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

language of work or name

0 references

publication date

30 August 2012

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22821757%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

International Journal of Cancer

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22821757%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

132

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22821757%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22821757%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

807-812

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22821757%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27733

21 January 2018

A fluorescence in situ hybridization screen for E26 transformation-specific aberrations: identification of DDX5-ETV4 fusion protein in prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27733

21 January 2018

Prevalence of TMPRSS2-ERG and SLC45A3-ERG gene fusions in a large prostatectomy cohort

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27733

21 January 2018

N-myc downstream regulated gene 1 (NDRG1) is fused to ERG in prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27733

21 January 2018

ERG rearrangement is specific to prostate cancer and does not occur in any other common tumor

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27733

21 January 2018

ERG protein expression and genomic rearrangement status in primary and metastatic prostate cancer--a comparative study of two monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27733

21 January 2018

ERG oncoprotein expression in prostate cancer: clonal progression of ERG-positive tumor cells and potential for ERG-based stratification

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27733

21 January 2018

Antibody-based detection of ERG rearrangement-positive prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27733

21 January 2018

Complications, urinary continence, and oncologic outcome of 1000 laparoscopic transperitoneal radical prostatectomies-experience at the Charité Hospital Berlin, Campus Mitte.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27733

21 January 2018

GOLPH2 protein expression as a novel tissue biomarker for prostate cancer: implications for tissue-based diagnostics

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27733

21 January 2018

ERG status is unrelated to PSA recurrence in radically operated prostate cancer in the absence of antihormonal therapy.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27733

21 January 2018

The utility of ERG/P63 double immunohistochemical staining in the diagnosis of limited cancer in prostate needle biopsies.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27733

21 January 2018

Antibody EPR3864 is specific for ERG genomic fusions in prostate cancer: implications for pathological practice.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27733

21 January 2018

Diagnostic utility of p501s (prostein) in comparison to prostate specific antigen (PSA) for the detection of metastatic prostatic adenocarcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27733

21 January 2018

Identifiers

10.1002/IJC.27733

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22821757%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22821757%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47355331&oldid=1797598149"